Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

16.0K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.0K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

9.7K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
9.7K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.2K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.2K
Glial Cells01:04

Glial Cells

94.9K
Overview
94.9K
Functions of the Lymphatic and Immune System01:28

Functions of the Lymphatic and Immune System

7.1K
The lymphatic system plays a crucial role in bolstering our immune system. It consists of a network of lymphoid organs, lymph, and lymphatic vessels that provide structural and functional support in safeguarding the body against pathogens such as viruses and bacteria.
The primary lymphoid organs, including the bone marrow and the thymus, serve as the maturation sites for lymphocytes. Secondary lymphoid organs, like the mucosa-associated lymphoid tissue, activate these lymphocytes and serve as...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.

Future oncology (London, England)·2026
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

Cancer research communications·2026
Same author

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Blood·2026
Same author

Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.

Neuro-oncology advances·2026
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K

Primary Central Nervous System Lymphoma.

Catherine H Han, Tracy T Batchelor

    Continuum (Minneapolis, Minn.)
    |December 5, 2017
    PubMed
    Summary
    This summary is machine-generated.

    High-dose methotrexate chemotherapy is the standard for newly diagnosed primary central nervous system (CNS) lymphoma, offering better outcomes than radiation alone. Further research explores rituximab and consolidative therapies for improved disease control.

    More Related Videos

    Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
    09:01

    Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

    Published on: November 17, 2020

    7.8K
    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
    12:52

    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

    Published on: November 28, 2015

    16.6K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
    10:52

    Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

    Published on: March 30, 2018

    11.7K
    Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
    09:01

    Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

    Published on: November 17, 2020

    7.8K
    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
    12:52

    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

    Published on: November 28, 2015

    16.6K

    Area of Science:

    • Neuro-oncology
    • Hematology
    • Clinical Medicine

    Background:

    • Primary central nervous system (CNS) lymphoma is a rare, aggressive non-Hodgkin lymphoma affecting the brain, spinal cord, or meninges.
    • Immunocompetent patients present unique diagnostic and management challenges.
    • This review focuses on recent therapeutic advancements for primary CNS lymphoma.

    Purpose of the Study:

    • To provide an overview of the clinical features, diagnosis, and management of primary CNS lymphoma in immunocompetent individuals.
    • To highlight recent advances in the treatment of primary CNS lymphoma.
    • To discuss the evolving therapeutic landscape, including chemotherapy, radiation, and novel agents.

    Main Methods:

    • Review of clinical trials and literature on primary CNS lymphoma management.
    • Analysis of treatment outcomes, including disease control and neurotoxicity.
    • Focus on methotrexate-based chemotherapy regimens and consolidative strategies.

    Main Results:

    • Methotrexate-based induction chemotherapy, with or without autologous stem cell transplantation or reduced-dose radiation, demonstrates durable disease control with less neurotoxicity than whole-brain radiation alone.
    • Whole-brain radiation therapy alone provides inadequate disease control and significant delayed neurocognitive impairment, particularly in elderly patients.
    • High tumor response rates are achievable with initial treatment, but relapse remains a significant concern.

    Conclusions:

    • Prompt diagnosis and treatment initiation are critical for improving outcomes in primary CNS lymphoma.
    • High-dose methotrexate-based chemotherapy is the current standard for newly diagnosed primary CNS lymphoma.
    • Ongoing trials investigating rituximab and consolidative therapies aim to further optimize treatment strategies and address relapse.